TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director July 29, 1988
TCL Archive Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center April 15, 1994